Elevra Lithium Limited has announced the signing of a non-binding Memorandum of Understanding (MoU) with Mangrove Lithium for the potential supply of spodumene concentrate produced at North American Lithium (NAL). The MoU outlines intentions to negotiate a definitive agreement under which Elevra could supply up to 144,000 tonnes per year of spodumene concentrate to Mangrove at market-related prices, subject to a floor and ceiling price. The proposed supply would cover an initial five-year period starting in 2028 and ramp up to the full volume by 2030, representing approximately 46% of Elevra's estimated sales volumes. A binding agreement is subject to Mangrove making a final investment decision before June 2027 on the construction of a lithium conversion facility and the parties reaching agreement on final terms.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elevra Lithium Limited published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-26-004706), on February 11, 2026, and is solely responsible for the information contained therein.